Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 8 | |
Outperform | 15 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 22 analysts offering 12 month price targets for Sarepta Therapeutics Inc have a median target of 198.50, with a high estimate of 219.00 and a low estimate of 147.12. The median estimate represents a 79.64% increase from the last price of 110.50.
High | 98.2% | 219.00 |
Med | 79.6% | 198.50 |
Low | 33.1% | 147.12 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +94.45% |
Average growth rate | +6.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.07% |
Average growth rate | +34.49% |
More ▼